PGY1 - PGY2 Medication-Use Safety and Policy
Program Type: ASHP Accredited PGY1/PGY2 Residency
ASHP Match Number: 536377
PGY1 Program Purpose
PGY1 pharmacy residency programs build on Doctor of Pharmacy education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification and eligible for postgraduate year two (PGY2) pharmacy residency training.
PGY2 Program Purpose
PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.
Program Overview
This two-year specialized residency in Medication-Use Safety and Policy offers advanced training that prepares the resident to assume a leadership role in devising and implementing system changes that improve the safety, efficiency, and appropriateness of the medication-use system.
The training experience in the first year is composed of four competency areas: 1) patient care; 2) advancing practice and improving patient care; 3) leadership and management; and 4) teaching, education and dissemination of knowledge. Our residents will have the opportunity to provide pharmaceutical care to patients in multiple settings, develop independent learning skills, maintain a professional ethic, provide effective medication education to others, understand research methods and opportunities, and assume personal responsibility for effecting change.
The training experience in the second year focuses on medication safety and quality improvement. The resident will work closely with the medication safety, quality, and formulary management teams to investigate medication-related events, assess compliance with regulatory standards and best practice recommendations related to medication-use safety, and develop and implement system changes to ensure safe and efficient use of medications. While the majority of rotations are completed at the hospital, there are also opportunities for away rotations at the Johns Hopkins Bayview Medical Center and The Institute for Safe Medication Practices (ISMP). The resident will also complete a longitudinal educational experience with the Armstrong Institute of Patient Safety and Quality Leadership Academy. Upon completion of this program, the individual will be well-positioned to function as a Medication Safety Officer in a health-system setting.
Program Goals
Residents who complete this program will be able to assume a leadership role in devising and implementing system changes that improve the safety, efficiency, and appropriateness of the medication-use system.
Residents will:
- Analyze complex systems to identify and correct system flaws
- Complete a longitudinal educational experience with the Armstrong Institute of Patient Safety and Quality Leadership Academy
- Design and complete a self-directed research project with a focusing on medication-use safety
- Develop effective communication techniques and understand the way human factors that impact the safety of patient care
- Learn and apply methods to promote a culture of safety
- Participate in the application of technologies that improve the medication-use process
- Participate and lead committees promoting medication safety
- Participate in the teaching of medication safety focused lectures at the University of Maryland School of Pharmacy
Orientation
The Pharmacy Residency Orientation experience provides a comprehensive and coordinated training program designed to provide incoming residents with an understanding of policies, procedures, and expectations for the pharmacy residency experience. During orientation, residents will participate in hospital, department, and division orientation, and will be exposed to department policies and resources.
Hospital and pharmacy department orientation is required for all new pharmacist hires at Johns Hopkins Hospital. The resident is expected to interact with members of the pharmacy department throughout orientation and to attend assigned orientation and training sessions.
Prior to the start of the residency program, residents will be given a full, detailed orientation itinerary.
Rotations
PGY1 Year Required Rotations
- Critical Care (1 month)
Choice of: Cardiac Care Unit (CCU)- Cardiovascular Surgical Intensive Care (CVSICU)
- Medical Intensive Care (MICU)
- Neurosciences Critical Care (NCCU)
- Surgical Intensive Care (SICU)
- Weinberg Intensive Care (WICU)
- Internal Medicine (1 month)
- Integrated Practice Rotation (2 months)
- Leadership Collaborative Rotation (1 month)
- Ambulatory Care (6 months longitudinal experience)
- Adult Internal Medicine Clinic (3 months)
- Anticoagulation Management Clinic (3 months)
PGY1 Elective Rotations (1 month each)
- Addiction Medicine
- Adult Hepatology Service
- Advanced Heart Failure and Heart Transplantation
- Ambulatory Oncology
- Antimicrobial Stewardship
- Benign Hematology and Hemostatic/Antithrombotic Stewardship
- Bone Marrow Transplant/Myeloma/Lymphoma
- Concentrated Leadership
- Emergency Medicine
- †† Epic Willow Inpatient Certification
- General Adult Infectious Diseases Consults
- General Cardiology
- Hematologic Malignancies
- Inpatient HIV/AIDS
- Investigational Drug Service
- Kidney and Pancreas Transplant
- Liver Transplant
- Medical Oncology
- Medication Quality and Outcomes
- ^Medication Safety – Adults
- Medication Safety - Pediatrics
- *Neonatal Intensive Care
- Oncology Clinical Decision Support
- Pain Management/Palliative Care
- *Pediatric Cardiac Intensive Care & Heart Transplant
- *Pediatric Emergency Medicine
- *Pediatric Infectious Diseases Consult
- *Pediatric Intensive Care
- *Pediatric Oncology
- *Pediatric Nephrology
- Pharmacy Management & Leadership
- Psychiatry
- Surgery Acute Care
- Transplant Nephrology
Click here for brief description of rotations.
*It is recommended that the General Pediatrics rotation be completed before taking these specialized pediatrics rotations.
††Epic Willow Inpatient Certification is only offered to the Pharmacy Informatics resident and is a required elective rotation for the Informatics resident during the PGY1 year.
^Medication Safety – Adults is a required elective rotation for the MUSP resident during the PGY1 year.
Additional elective rotations may be available pending resident interest and preceptor availability. Residents are required to spend at least 2/3rd of the program in direct patient care activities.
PGY2 Year Required Rotations
Core block rotations (4-8 weeks each)
- PGY2 MUSP - Medication Safety in Adult Medicine, Critical Care, and Surgery (8 weeks)
- PGY2 MUSP - Formulary and Systems Integration (4 weeks)
- PGY2 MUSP - Medication Safety in Pediatrics (8 weeks)
- PGY2 MUSP - Medication Safety in Oncology (8 weeks)
- PGY2 MUSP - Medication Safety at Bayview Medical Center (4 weeks)
- PGY2 MUSP – Quality Improvement and Regulatory Affairs (4 weeks)
- PGY2 MUSP – Clinical Informatics
Core longitudinal rotations (9-12 months each)
- PGY2 MUSP – Longitudinal Staffing (12 months)
- PGY2 MUSP – Longitudinal On-Call (12 months)
- PGY2 MUSP - Longitudinal Education and Teaching Experience (12 months)
- PGY2 MUSP – Longitudinal Research Project (12 months)
- PGY2 MUSP – Longitudinal Medication-Use Policy and Formulary Management (9 months)
PGY2 Year Elective Rotations
Block rotations (4 week)
- PGY2 MUSP- Institute for Safe Medication Practices (ISMP) (4 weeks)
- PGY2 MUSP- Central Pharmacy Operations and Automation (4 weeks)
- Other elective learning experiences may be developed based on resident interest and preceptor availability
Education Components
- Pharmacotherapy Rounds
- All residents, during both the PGY1 and PGY2 years, will provide a 30-minute presentation that is APCE accredited.
- Please refer to the “Learning Opportunities” section of the Department of Pharmacy, Johns Hopkins Medicine website.
- Journal Clubs and/or Topic Discussions
- Example topics:
- Change Management Principles
- High Alert Medications & Strategies to Minimize Errors
- Just Culture and Systems Thinking
- Safety Implications of Drug Shortages
- Joint Commission Readiness
- Teaching Requirements
- The PGY2 resident will provide a 60-minute Medication Safety Continuing Education presentation that is APCE accredited.
- The PGY2 resident will provide a medication safety focused lecture for students at the University of Maryland School of Pharmacy
- Please refer to the “Learning Opportunities” section of the Department of Pharmacy, Johns Hopkins Medicine website.
Requirements for Acceptance to the Program
The qualified candidate will have a Doctor of Pharmacy degree from an ACPE accredited school of pharmacy. Prior to the beginning of a PGY2 residency, PGY2 residents must have successfully completed an ASHP-accredited PGY1 pharmacy residency program.
Licensure and Certification Requirements
All residents are expected to obtain a Maryland State Pharmacy License by August 1st.
The resident will arrive at the program already ACLS certified, or will complete certification during the residency year.
Program-specific Experiences
- - Armstrong Institute Patient Safety and Quality Leadership Academy
- This is a 9-month training program that includes didactic and discussion sessions, Lean Sigma training, completion of a patient safety or quality improvement project, and attendance at institutional quality and safety meetings.
Attendance at Professional Meetings
The department will support the resident (expense and leave time) to attend the Eastern States Residency Conference during the PGY1 and PGY2 years, and the ASHP Midyear Clinical meeting during the PGY2 year. Alternative meeting forums (e.g. ASHP Summer Meeting) can be considered to allow the resident the best forum to present their research project, and at the discretion of the RPD and the department. Any additional travel that is to be supported by the department is evaluated on a case-by-case basis.
Please refer to the “Meetings and Conferences” section of the Department of Pharmacy, Johns Hopkins Medicine website.
Medication-Use Evaluation (MUE) Project
The resident, during both PGY1 and PGY2 years, must complete a self-directed research or quality improvement project. The scope, magnitude, and type of project will vary according to individual interests but must be completed in a manner suitable for presentation and publication.
Please refer to the “Projects” section of the Department of Pharmacy, Johns Hopkins Medicine website.
Drug Class Review (DCR) or Formulary Management Project
The PGY2 resident will complete a drug class review as part of the formulary management process. This may be achieved through assisting in the determination of formulary additions/deletions by assessing therapeutic merits, safety, redundancies, and the estimated cost impact on the JHHS.
Committee Participation
The resident will be assigned to departmental, hospital, or health-system committee(s) over the course of the year. The resident will serve as the secretary for the Medication Event Review and Intervention Team (MERIT). The resident will help support both the Significant Medication Event (SME) and Pediatric Medication Safety Committees.
Staffing Component
Each resident will practice as a pharmacist in a designated area throughout the residency year.
Please refer to the “Staffing Requirements” section of the Department of Pharmacy, Johns Hopkins Medicine.
On-Call Coverage
The resident will participate in clinical on-call services. On-call duties include adult and pediatric code response, trauma and stroke calls, administrative assistance, and other duties. On-call hours are from 4 PM to 10 PM on weekdays and 8 AM to 8 PM on weekends and holidays. The frequency of on-call coverage depends upon the number of residents in the entire program and averages about 15 shifts per year.
Please refer to the “On Call Program” section of the Department of Pharmacy, Johns Hopkins Medicine website.
Paid Time Off (PTO)
Please refer to the “Benefits” section of the Department of Pharmacy, Johns Hopkins Medicine website.
Residency Program Director
Rosemary J. Duncan, PharmD
Medication Safety Officer
The John Hopkins Hospital
Department of Pharmacy
600 North Wolfe Street, Carnegie 180
Baltimore, MD 21287-6180
Phone: 443-287-6850
Email: [email protected]Residency Program Coordinator
Meghan Rowcliffe, PharmD
Pediatric Medication Safety Officer
The John Hopkins Hospital
Department of Pharmacy
600 North Wolfe Street, Carnegie 180
Baltimore, MD 21287-6180
Phone: 410-502-6594
Email: [email protected] - Example topics: